How Do Depression Medications Taken By Pilots Affect Passengers' Willingness to Fly? A Mediation Analysis

The mental health of airline pilots has been a concern for decades. In 2010, the United States Federal Aviation

Administration began allowing four types of selective serotonin reuptake inhibitors (SSRIs) to be used by pilots

suffering from depression. After a procedural wait period, pilots may be awarded a special issuance of their

medical certificates to maintain flight currency. Missing from the literature was any research on consumer’s

perceptions of pilots taking antidepressants, along with some other approved medications. Therefore, the purpose

of the current study was to examine consumer’s willingness to fly once told that the pilot of their hypothetical

flight was taking medication compared to a control group in which the pilot was not on any prescribed and

approved medications. The current study also manipulated dosage levels and gathered affect data to determine if

consumers’ responses were rationally or emotionally motivated. Across two studies, consumers were less willing

to fly when the pilot was taking medication, and when the medication was a high dose opposed to a low dose.

Additionally, affect was found to completely mediate the relationship between three of the four medications

when compared to the control condition, suggesting that participants’ responses were emotionally driven. Finally,

a discussion of the findings and practical implications of the study are provided.